The Cell Therapy Packaging Products and Services Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031.
Key Industry Insights & Findings from the Report:
- The increasing demand for proteins designed for various applications like therapeutic proteins, enzymes, and research reagents is driving the cell therapy packaging products and services market.
- The availability of funding for new cell lines is driving the cell therapy packaging products and services market.
- North America dominated the market and accounted for a global revenue share in 2023.
- The key challenges for the cell therapy packaging products and services market are the complexity of packaging, labelling, and distributing cell or gene therapy products.
Cell and gene therapies are growing at a rapid rate. Cell therapy includes the introduction of live cells into a patient’s body to repair or replace damaged tissues The increasing advancements in packaging and labelling are expected to drive the growth of the cell therapy packaging products and services market during the forecast period. As gene and cell therapy are gaining more acceptance, companies involved in logistics will require exceptional technology and novel ways to address supply chain issues. Further, suppliers of supply chain solutions will need a cold chain logistic network and cryogenic facilities to facilitate investigations and evaluate the safety and efficacy of cell and gene treatments. For instance, In Jan 2022, Catalent expanded its cold chain packaging capabilities at its Philadelphia location to meet the rising demand for biological medication delivery and breakthrough cell and gene treatments. The new suites offer complete serialization capabilities specially tailored for small-scale commercial product quantities.
Major driving factors in the market of cell therapy packaging products and services are the increasing need for cell and gene therapies, the high prevalence of cancer diseases and the rising number of clinical trials. Furthermore, advanced medical technologies, the growing trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios are enhancing the growth of the cell therapy packaging products and services market. However, the high cost of manufacturing systems, lack of standard therapy protocols, and shortage of skilled professionals limit the growth of this market.
Competitive Landscape
Some major key players in the Cell Therapy Packaging Products and Services Market:
- Almac,
- Catalent Pharma Solutions,
- Cryoport Systems,
- Core Cryolab Inc.,
- Yourway,
- Lufthansa Cargo,
- Saint-Gobain Life Sciences,
- Thermo Fisher Scientific,
- Sharp,
- West Pharmaceutical Services,
- Chart Industries Inc.,
- Other Prominent Players
Market Segmentation
Segmentation of cell therapy packaging products and services market includes Therapy, Package Engineering Design, Scale of Operation, and Region. The Therapy segment is segmented into T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies, and Other ATMPs. T-cell Therapies will be the key segment to drive the growth of this market. By Scale of Operation, the market is divided into Clinical and Commercial. In terms of Package Engineering Design, the market can be divided into Primary Packaging and Secondary Packaging. Based on the region, the cell therapy packaging products and services market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America, followed by Europe, hold the maximum share of this market due to increased research and development expenditure, the presence of significant market players and the fast adoption of advanced technologies.
Recent Developments:
- In October 2023, Cryoport entered a partnership with Be the Match BioTherapies to expand the capabilities of IntegriCell™, which is a bioprocessing, cryopreservation, and distribution solution for the cell therapy market.
The Cell Therapy Packaging Products and Services Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 20.0 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Therapy, By Package Engineering Design, By Scale of Operation |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Almac, Catalent Pharma Solutions, Cryoport Systems, Core Cryolab Inc., Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific, Sharp, West Pharmaceutical Services, Chart Industries Inc., and Other Prominent Players |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
